At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 85 enrolled
Drug / intervention
Dexamethasone +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Perineural Steroids for Saphenous Peripheral Nerve Blocks: An Equivalency Dosing Study.
In Brief
A Phase 4 clinical trial evaluating Dexamethasone, Bupivacaine, and 2 other interventions for Osteoarthritis, Knee. Completed, enrolled 85 participants across 1 site.
Detailed Summary
This study will look at the efficacy of dexamethasone for prolongation of peripheral nerve blocks.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Knee
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 2015
Enrollment StartJul 2015
Primary CompletionAug 2017
TodayJul 2026
First PostedJun 3, 2015
Enrollment StartJul 1, 2015
Primary CompletionAug 31, 2017
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 11.1 years ago
Interventions
Dexamethasonedrug
Used in nerve block mixture
Bupivacainedrug
Used in nerve block mixture
Epinephrinedrug
Used in nerve block mixture
Saphenous Peripheral Nerve Blockprocedure
Peripheral nerve block.